Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma is a research paper published in Metabolites (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01 CA250378
NIH
Grant: R21 CA259440
NIH
Grant: P30 CA069533
NIH
Grant: P30 CA069533 13S5
NIH
Grant: GM103440
NIH
Grant: GM104944
NIH
Grant: RRID:SCR_009961
NIH
Grant: NIH P30 CA069533
NIGMS NIH HHS
Grant: U54 GM104944
NICHD NIH HHS
Grant: P01 HD034430
NCI NIH HHS
Grant: R21 CA222455
NIH HHS
Grant: 1R01CA250378-04
NIGMS NIH HHS
Grant: P20 GM103440
National Institutes of Health
Grant: 5R01CA250378-03
Developing novel polytherapies for Non-Clear Cell Renal Cell Carcinoma
National Institutes of Health
Grant: 3P30CA069533-21S3
OHSU Knight Cancer Institute
National Institutes of Health
Grant: 4U54GM104944-04
Clinical and Translational Research Infrastructure Network IDeA-CTR
National Institutes of Health
Grant: 8P20GM103440-11
IDeA Network for Biomedical Research Excellence
National Institutes of Health
Grant: 1R21CA259440-01
Novel Treatment Strategies for Cancer
FWCI
1.11
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals